SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.

Dealing with cancer is a journey. Along the way, you may have questions about SUTENT. Call the SUTENT Patient Call Center at
1-877-5-SUTENT. The SUTENT Patient Call Center does not provide medical advice and will never replace your doctor or nurses. The call center’s trained Oncology Nurse Consultants can help you:
- Learn about your treatment with SUTENT
- Understand its potential side effects
- Get information about GIST
You can reach the SUTENT Patient Call Center Monday through Friday, 8 AM to 7 PM CT at 1-877-5-SUTENT (1-877-578-8368).
 |
In order to view PDF documents, you must have Adobe® Reader®
installed on your computer. If you do not have Adobe Reader, download it from the
Adobe Web site.
|
Note that the Adobe Web site is neither owned nor controlled by Pfizer. Pfizer is
not responsible for the content or services on that site.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated
in the United States and/or other countries.